Make an appointment
Lymphoma Division comprises a specialized team of professionals who are dedicated to preventing, diagnosing, treating, and managing cancers of the lymphatic system, including Hodgkin's disease and non-Hodgkin's lymphoma. The lymphoma team also cares for patients with serious, potentially fatal blood disorders such as amyloidosis.
The lymphoma team brings together experts in hematology/medical oncology, immunology, stem cell transplantation, infectious diseases, pathology, radiation oncology, transfusion medicine, orthopedics, and nursing. This specialized approach to treating lymphoma provides patients with the exact type of services they need to battle the disease and its physical, emotional, and social side effects.
Primary Central Nervous System Lymphoma
The Lymphoma Division Team
ANDRE GOY, M.D., M.S.
Hematologist/oncologist Andre Goy, M.D., M.S., is an internationally renowned clinician and researcher of all types of lymphoma, including Hodgkin's disease, non-Hodgkin's lymphoma, and HIV-associated lymphoma. As chief of The Cancer Center's Division of Lymphoma, he leads New Jersey's largest program of research, treatment, and management of lymphoma. Dr. Goy has trained and/or worked at some of the world's leading medical institutions, including Memorial Sloan-Kettering Cancer Center in New York City; The University of Texas' M.D. Anderson Cancer Center, in Houston; University Hospitals Group of Paris, France; and The Pasteur Institute in Paris. Read full bio.
TATYANA FELDMAN, M.D.
Tatyana Feldman, M.D. specializes in the treatment of lymphoma, including Hodgkin's disease and non-Hodgkin's lymphoma. She joined the John Theurer Cancer Center in 2006, bringing more than 15 years of experience in internal medicine, hematology, and oncology. Dr. Feldman currently serves as an Attending in the Lymphoma Division at the John Theurer Cancer Center. Prior to her current position, Dr. Feldman was on faculty in Hematology Division at NYU Medical center.
Dr. Feldman is actively involved in research related to lymphoma. She has presented at medical meetings, including some of the most well-known in the world, such as the American Society of Hematology. In addition, she is currently the principal investigator for a number of clinical trials being conducted at the John Theurer Cancer Center. Her research interests include finding new therapies for lymphomas including some rare lymphomas such as T cell lymphoma, cutaneous and EBV-driven lymphomas. Read full bio.
ANTHONY R. MATO, M.D., M.S.C.E.
Hematologist /oncologist Anthony R. Mato, M.D., M.S. is an Attending in the Division of Lymphoma at the John Theurer Cancer Center. He joined the Cancer Center in 2009, bringing a world-class education and more than eight years of experience in internal medicine, hematology and oncology.
Dr. Mato offers an impressive background in research, which includes in-depth studies on hematologic malignancies. His research interest lies in lymphocytic leukemia and small lymphocytic lymphoma. He has been extensively published in hematology and oncology journals such as Blood, Journal of Cellular Biochemistry, and Leukemia and Lymphoma. His research has been presented at international medical conferences, including the two of the largest in the world: the American Society of Clinical Oncology and the American Society of Hematology. Dr. Mato has been the lead researcher for many of these studies. Dr. Mato currently reviews abstracts for the American Society of Hematology, and manuscripts for Cancer Biology and Therapy, American Journal of Hematology, and Annals of Internal Medicine. Read full bio.
Pritish Bhattacharyya, M.D.
Roxana Kline, M.D.
Mary Ann Michelis, M.D.
Rani Sebti, M.D.
Thomas Selvaggi, M.D.
Advanced Practice Nurse/Clinician